Literature DB >> 29943664

Assessing Cost of Robotic Utilization in Partial Nephrectomy with Increasing Utilization.

Clinton D Bahler1, Maria Francesca Monn1, Chandra K Flack1, Alec R Gramm1, Thomas A Gardner1, Chandru P Sundaram1.   

Abstract

PURPOSE: To evaluate trends in utilization of robotic assistance in partial nephrectomy (PN) and assess the association between cost and utilization. PATIENTS AND METHODS: Using the 2009-2012 Nationwide Inpatient Sample database, we identified all adult (>17 years) patients undergoing PN for localized primary renal malignancy. Coding for robotic assistance (17.4 × ) began in the final quarter of 2008. The primary outcome was total hospital cost exclusive of physician fees. A multiple linear regression model was used to adjust for patient and hospital characteristics.
RESULTS: Between 2009 and 2012, there were 32,664 (58%) open, 3498 (6%) laparoscopic, and 20,350 (36%) robot-assisted partial nephrectomies performed in the United States. Between 2009 and 2012, the total number of partial nephrectomies semiannually increased by 93% (5114-9845) with robotic partial nephrectomies (RPNs) representing >80% of the increase. RPN increased from 1029 cases in the first half of 2009 to 4840 in the last half of 2012 and surpassed utilization of open nephrectomy. The proportion of all partial nephrectomies performed with robotic assistance increased from 20% to 49% during the same period. After adjusting for demographics, Charlson comorbidity index, and hospital region, RPN went from $1,464 (p = 0.009) more than open in 2009 to $456 (p = 0.28) less than open in 2012.
CONCLUSIONS: Utilization of RPN surpassed open in 2012 in the United States. The difference in cost between the robotic and open approaches decreased during the study period and by 2011 was not statistically different.

Entities:  

Keywords:  carcinoma; cost and cost analysis; economics; nephrectomy; renal cell; robotics

Mesh:

Year:  2018        PMID: 29943664     DOI: 10.1089/end.2018.0170

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  4 in total

1.  Rising Economic Burden of Renal Cell Carcinoma among Elderly Patients in the USA: Part II-An Updated Analysis of SEER-Medicare Data.

Authors:  Ya-Chen Tina Shih; Ying Xu; Chun-Ru Chien; Bumyang Kim; Yu Shen; Liang Li; Daniel M Geynisman
Journal:  Pharmacoeconomics       Date:  2019-12       Impact factor: 4.981

Review 2.  Economic Burden of Renal Cell Carcinoma-Part I: An Updated Review.

Authors:  Chun-Ru Chien; Daniel M Geynisman; Bumyang Kim; Ying Xu; Ya-Chen Tina Shih
Journal:  Pharmacoeconomics       Date:  2019-03       Impact factor: 4.981

3.  Comparison of 1-Year Health Care Expenditures and Utilization Following Minimally Invasive vs Open Nephrectomy.

Authors:  Kennedy E Okhawere; Gediwon Milky; I-Fan Shih; Yanli Li; Ketan K Badani
Journal:  JAMA Netw Open       Date:  2022-09-01

4.  Development and validation of a porcine organ model for training in essential laparoscopic surgical skills.

Authors:  Madoka Higuchi; Takashige Abe; Kiyohiko Hotta; Ken Morita; Haruka Miyata; Jun Furumido; Naoya Iwahara; Masafumi Kon; Takahiro Osawa; Ryuji Matsumoto; Hiroshi Kikuchi; Yo Kurashima; Sachiyo Murai; Abdullatif Aydin; Nicholas Raison; Kamran Ahmed; Muhammad Shamim Khan; Prokar Dasgupta; Nobuo Shinohara
Journal:  Int J Urol       Date:  2020-08-03       Impact factor: 3.369

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.